Andrew R Mendelsohn

Title: The Innovations of Andrew R Mendelsohn

Introduction

Andrew R Mendelsohn is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of biotechnology, particularly in the treatment of obesity and growth hormone deficiencies. With a total of 4 patents to his name, Mendelsohn's work is characterized by innovative approaches to immunogenicity and therapeutic methods.

Latest Patents

Mendelsohn's latest patents include groundbreaking methods for enhancing somatostatin immunogenicity in the treatment of obesity. These compositions and methods provide novel vaccines that increase the release of endogenously produced growth hormone and/or insulin-like growth factor 1 in patients. Another significant patent involves chloramphenicol acetyl transferase (CAT)-defective somatostatin fusion proteins. This patent details chimeric somatostatin-based polypeptides and the methods for isolating and producing these polypeptides, along with low-cost adjuvants that enhance immunogenic responses. These innovations are particularly useful in facilitating farm animal productivity.

Career Highlights

Mendelsohn is currently associated with Braasch Biotech LLC, where he continues to develop and refine his innovative ideas. His work has garnered attention in the biotechnology community, contributing to advancements in therapeutic treatments.

Collaborations

Mendelsohn has collaborated with notable professionals in his field, including Keith N Haffer and James W Larrick. These collaborations have further enriched his research and development efforts.

Conclusion

Andrew R Mendelsohn's contributions to biotechnology through his patents and innovative methods highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in treatment methodologies and agricultural productivity.